openPR Logo
Press release

Global Antacid Market Share, Size, Growth & Forecast 2021

06-30-2017 09:12 AM CET | Health & Medicine

Press release from: Market Data Forecast

"Browse And Choose From Our World Class Research Reports"

"Browse And Choose From Our World Class Research Reports"

The Global Antacid Market was worth USD 3,790 million in 2016 and estimated to be growing at a CAGR of 2.5%, to reach USD 4,290 million by 2021. The market is showcasing evident potential in the mentioned forecasting period. It is expected to show significant growth in coming years because of the people being habitual of indulging in poor eating habits and resultantly facing stomach problems. The number of cases of people falling sick have been rising significantly lately.

Antacid are substances used to neutralize acidity in stomach, which in turn relieves stomach upset, heartburn and indigestion. In case of excessive secretion of acids in the digestive system, the natural mucous barrier responsible for protecting the lining in the stomach can damage the oesophagus. Increasing cases of stomach problems experienced by people has led to companies gaining interest in the Antacids market recently.

Full report at: http://www.marketdataforecast.com/market-reports/global-antacid-market-2360/

Antacids directly target the excess acids and get rid of them unlike other medications which reduce or prevent stomach acid excretion. Hence it shows better results compared to other medications. Further, Antacid come either as a chewable gum, liquid or a tablet, thus being easy to use by patients across all age groups. These factors have been driving the growth of the Antacid market lately. On the other hand, there are some restraints that are faced by antacids which include certain side effects like constipation, laxative effect, and allergic reactions. Further people with certain medical conditions are prone to adverse effects worsening their health conditions like people with heart conditions may face problems due to high amount of sodium present in Antacids.

The Global market for Antacid is segmented based on submarkets, applications and ingredients. By submarkets the market is further segmented under Chromatography, E-Clinical Trial Solutions, Wireless Health, Healthcare IT outsourcing, Clinical Trial Management Systems(CTMS), Immunoassay, Digital Pathology, Next Generation sequencing(NGS), Proteomics, Antacids with Antiflatulents. By Application the market is segment into Novel dietary fibers. Coming to ingredients the market is segmented under Protease, Modified starch, Food & Beverage Starch, Gelatin, Collagen, Carbohydrase, Food & Beverage Sugars & its substitutes. Under submarket segment, Chromatography accounted for the highest share in the market followed by Clinical Trial Management Systems (CTMS). Based on Ingredients segmentation, protease leads the market share. Under geography analysis, the global market is segmented under various regions namely Europe, North America, Asia-Pacific, Latin America and MENA. The Antacid market was dominated by North America, with the overall market share of over 45% globally. North America was followed by Europe and Asia-Pacific. Asia Pacific is predicted to grow at a rapid pace in the coming few years.

Request sample: http://www.marketdataforecast.com/market-reports/global-antacid-market-2360/request-sample

Some of the major leaders for the Antacid market include First Aid Only, WellSpring Pharm, GSK, Private Lable, Pfizer, Procter & Gamble, Glaxosmithkline, Boehringer Ingellheim Pharm, Novaritis Consurmer Health, Johnson & Johnson.

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

Contact:

Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antacid Market Share, Size, Growth & Forecast 2021 here

News-ID: 603326 • Views: 309

More Releases from Market Data Forecast

Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to incre …
Overview: Veterinary Vaccines Market has seen significant growth over the past few years, due to alarm of imminent epidemics that have led to substantial losses, particularly in poultry segment. View sample and decide: https://www.marketdataforecast.com/market-reports/veterinary-vaccines-market-75/customize-report Market views: Global Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to increase to reach a market value to USD 8.46 Billion by 2023. Drivers and restraints: Veterinary Vaccine market has displayed a noteworthy growth in recent years which
Protein Labelling Market Global Growth, Trends, And Forecast To 2024
Recent developments: Proteins are the biggest and most essential biomolecules in a living life form, as they are imperative to the working of a creature. When they are shaped inside a cell, proteins associate with different biomolecules and do jobs to keep the cell alive. Merck's FITC labeling kit gives intends to rapidly and just mark antibodies or different proteins with fluorescein. Coordinate marking of the essential immune response disposes of the
Agricultural biotechnology market– Dupont opened its integrated science and bi …
Recent Developments Du Pont is a science and technology company. This company introduce agriculture products, containing the soybean seed and hybrid corn varients mainly under the brand named Pioneer, canola, sorghum, sunflower,  wheat, and rice seeds; silage inoculants, and insect,  weed, disease control products, DuPont introduced its first integrated science and biotechnology center, the DuPont Knowledge Center (DKC) in Hyderabad, Telangana state, in 2008. It is a 20-acre campus with a recent
The endovenous ablation segment is expected to command the major share of the Eu …
Overview The Europe Varicose Vein Treatment Market was worth USD 95.4 million in 2018 and estimated to be growing at a CAGR of 6.3%, to reach USD 129.49 million by 2023. The varicose vein treatment market is mainly driven by the rising cases of varicose veins. This condition of enlarged veins appears mostly in feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders and high blood pressure. View a

All 5 Releases


More Releases for Antacid

Global Antacid Tablet Sales Market Report
In this report, the global Antacid Tablet market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Antacid Tablet for these regions, from 2013 to 2025
Global Antacid Tablet Sales Market Report
In this report, the global Antacid Tablet market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Antacid Tablet for these regions, from 2013 to 2025
Antacid Market Size, Share, Trends and Analysis 2021
Antacid Market by Submarkets (Chromatography, E-Clinical Trial Solutions, Wireless Health, Clinical Trial Management Systems(CTMS), Healthcare IT outsourcing, Immunoassay, Digital Pathology, Next Generation sequencing(NGS), Proteomics, Antacids with Antiflatulents) by Applications (Novel Dietary Fibers) by Ingredients (Protease, Modified starch, Food & Beverage Starch, Gelatin, Collagen, Carbohydrase, Food & Beverage Sugars & its substitutes), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) The Global Antacid Market was worth
Antacid Medications Market, Company Analysis and Forecast to 2024
Antacid Medications Market Overview Antacids are used to treat acid reflux that causes heartburn, indigestion, and stomach upset. They provide quick relief from heartburn, which is a major symptom of gastroesophageal reflux disease and indigestion. Treatment with antacids is symptomatic and is usually recommended for minor symptoms. Antacids include magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids with magnesium may cause diarrhea, while
Antacid Medications Market, Company Analysis and Forecast to 2024
Antacid Medications Market Overview Antacids are used to treat acid reflux that causes heartburn, indigestion, and stomach upset. They provide quick relief from heartburn, which is a major symptom of gastroesophageal reflux disease and indigestion. Treatment with antacids is symptomatic and is usually recommended for minor symptoms. Antacids include magnesium carbonate, aluminum hydroxide, and magnesium trisilicate. Some people have reported allergic reactions to antacids. Antacids with magnesium may cause diarrhea, while
Antacid Medications Market - Trends, Outlook, and Opportunity Analysis, 2016–2 …
Global players operating in the antacid medications market Various companies manufacture antacids and other products for indigestion. Some of these are GlaxoSmithKline plc, Dabur India Limited, Abbott Laboratories, and Pfizer, Inc. Sun Pharma launched an ayurvedic digestive remedy called Pepmelt to compete with popular antacids such as Eno (GSK consumer healthcare), Digene (Abbott India), Pudin Hara (Dabur), and Gelusil (Pfizer). According to 2014 estimates of the National Institute of Diabetes and